Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activity.
J Med Chem. 2004 Jan 29;47(3):530-49. doi: 10.1021/jm030913e.
J Med Chem. 2004.
PMID: 14736235
Discovery of orally bioavailable NK1 receptor antagonists.
Genicot C, Christophe B, Collart P, Gillard M, Goossens L, Hénichart JP, Lassoie MA, Moureau F, Neuwels M, Nicolas JM, Pasau P, Quéré L, Ryckmans T, Stiernet F, Taverne T, Van Keulen BJ.
Genicot C, et al.
Bioorg Med Chem Lett. 2003 Feb 10;13(3):437-42. doi: 10.1016/s0960-894x(02)00956-3.
Bioorg Med Chem Lett. 2003.
PMID: 12565946
Item in Clipboard
Discovery of heterocyclic nonacetamide synaptic vesicle protein 2A (SV2A) ligands with single-digit nanomolar potency: opening avenues towards the first SV2A positron emission tomography (PET) ligands.
Mercier J, Archen L, Bollu V, Carré S, Evrard Y, Jnoff E, Kenda B, Lallemand B, Michel P, Montel F, Moureau F, Price N, Quesnel Y, Sauvage X, Valade A, Provins L.
Mercier J, et al.
ChemMedChem. 2014 Apr;9(4):693-8. doi: 10.1002/cmdc.201300482. Epub 2014 Jan 20.
ChemMedChem. 2014.
PMID: 24446373
Item in Clipboard
Optimization of 8-Hydroxyquinolines as Inhibitors of Catechol O-Methyltransferase.
Buchler I, Akuma D, Au V, Carr G, de León P, DePasquale M, Ernst G, Huang Y, Kimos M, Kolobova A, Poslusney M, Wei H, Swinnen D, Montel F, Moureau F, Jigorel E, Schulze MED, Wood M, Barrow JC.
Buchler I, et al.
J Med Chem. 2018 Nov 8;61(21):9647-9665. doi: 10.1021/acs.jmedchem.8b01126. Epub 2018 Oct 19.
J Med Chem. 2018.
PMID: 30272964
Free PMC article.
Item in Clipboard
Synthesis and Evaluation of Bicyclic Hydroxypyridones as Inhibitors of Catechol O-Methyltransferase.
Ernst G, Akuma D, Au V, Buchler IP, Byers S, Carr GV, Defays S, de León P, Demaude T, DePasquale M, Durieu V, Huang Y, Jigorel E, Kimos M, Kolobova A, Montel F, Moureau F, Poslusney M, Swinnen D, Vandergeten MC, Van Houtvin N, Wei H, White N, Wood M, Barrow JC.
Ernst G, et al.
ACS Med Chem Lett. 2019 Oct 22;10(11):1573-1578. doi: 10.1021/acsmedchemlett.9b00345. eCollection 2019 Nov 14.
ACS Med Chem Lett. 2019.
PMID: 32038769
Free PMC article.
Item in Clipboard
A reversible monoamine oxidase A inhibitor, befloxatone: structural approach of its mechanism of action.
Wouters J, Moureau F, Evrard G, Koenig JJ, Jegham S, George P, Durant F.
Wouters J, et al.
Bioorg Med Chem. 1999 Aug;7(8):1683-93. doi: 10.1016/s0968-0896(99)00102-9.
Bioorg Med Chem. 1999.
PMID: 10482460
Item in Clipboard
Experimental and theoretical study of reversible monoamine oxidase inhibitors: structural approach of the active site of the enzyme.
Wouters J, Moureau F, Vercauteren DP, Evrard G, Durant F, Koenig JJ, Ducrey F, Jarreau FX.
Wouters J, et al.
J Neural Transm Suppl. 1994;41:313-9. doi: 10.1007/978-3-7091-9324-2_41.
J Neural Transm Suppl. 1994.
PMID: 7931244
Item in Clipboard
Cite
Cite